Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery... Show more
a developer of manufactures and sells precision photonic and motion control components
Industry ElectronicEquipmentInstruments
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BCLO | 49.74 | 0.25 | +0.51% |
| iShares BBB-B CLO Active ETF | |||
| IUSB | 46.30 | 0.16 | +0.36% |
| iShares Core Universal USD Bond ETF | |||
| GGLS | 6.09 | N/A | N/A |
| Direxion Daily GOOGL Bear 1X ETF | |||
| FXF | 108.92 | -0.13 | -0.12% |
| Invesco CurrencyShares® Swiss Franc | |||
| KOKU | 128.64 | -0.43 | -0.33% |
| Xtrackers MSCI Kokusai Equity ETF | |||
A.I.dvisor indicates that over the last year, NOVT has been loosely correlated with ST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NOVT jumps, then ST could also see price increases.
| Ticker / NAME | Correlation To NOVT | 1D Price Change % | ||
|---|---|---|---|---|
| NOVT | 100% | N/A | ||
| ST - NOVT | 52% Loosely correlated | +1.81% | ||
| VPG - NOVT | 51% Loosely correlated | +5.50% | ||
| TDY - NOVT | 40% Loosely correlated | +4.00% | ||
| BKSY - NOVT | 40% Loosely correlated | -1.52% | ||
| TRMB - NOVT | 35% Loosely correlated | N/A | ||
More | ||||
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NOVT advanced for three days, in of 306 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where NOVT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 30, 2026. You may want to consider a long position or call options on NOVT as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 205 cases where NOVT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for NOVT moved out of overbought territory on June 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for NOVT turned negative on June 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NOVT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NOVT broke above its upper Bollinger Band on June 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NOVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NOVT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.228) is normal, around the industry mean (4.550). P/E Ratio (111.986) is within average values for comparable stocks, (98.035). NOVT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.639). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.879) is also within normal values, averaging (29.590).